- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Renovare Therapeutics Launches, Partners with CU Boulder Researcher
New biotech startup collaborates with award-winning university scientist on novel treatments.
Apr. 7, 2026 at 2:21am
Got story updates? Submit your updates here. ›
A new partnership between a biotech startup and a university researcher aims to translate cutting-edge science into innovative medical treatments.Boulder TodayRenovare Therapeutics, a newly formed private biotech company, has announced its launch and a collaboration with a researcher at the University of Colorado Boulder. The startup will work with the CU Boulder scientist on developing innovative therapeutic treatments, combining the university's research expertise with Renovare's drug development capabilities.
Why it matters
The partnership between Renovare and CU Boulder represents an exciting opportunity to translate cutting-edge academic research into real-world medical solutions. Collaborations between industry and academia can accelerate the development of novel therapies and help bridge the gap between scientific discovery and clinical application.
The details
Renovare Therapeutics was founded to advance new treatments in areas of high unmet medical need. The company will leverage the research of its CU Boulder collaborator, who has received prestigious awards for their work in regenerative medicine and tissue engineering. Together, Renovare and the university scientist will focus on developing innovative therapies that could improve patient outcomes in a range of therapeutic areas.
- Renovare Therapeutics was founded in 2026.
- The company announced its launch and collaboration with CU Boulder on April 6, 2026.
The players
Renovare Therapeutics, Inc.
A privately-held biotech startup founded in 2026 to advance new treatments in areas of high unmet medical need.
University of Colorado Boulder
A public research university located in Boulder, Colorado, known for its excellence in scientific research and innovation.
What’s next
Renovare and the CU Boulder researcher will now begin the process of developing and testing potential therapeutic candidates, with the goal of advancing promising treatments into clinical trials.
The takeaway
The partnership between Renovare Therapeutics and the University of Colorado Boulder represents an exciting opportunity to translate cutting-edge academic research into real-world medical solutions, potentially leading to new and improved treatments for patients.
Boulder top stories
Boulder events
Apr. 7, 2026
Pat MethenyApr. 10, 2026
Lily Rose - All Ages (under 16 with adult)



